Jaguar Health, Inc. (JAGX) short interest & options flow
NASDAQJaguar Health heads into its May 21 earnings report with the lending market telling a more alarming story than the short interest numbers alone suggest. The borrow market has tightened dramatically over the past month. Cost to borrow has surged to 234% annualised — more than eleven times the ~21% level recorded at end-April. That move reflects acute scarcity: availability has been…
JAGX short interest plummets 25.3% in a week to 2.9% of float, lowest level in months, as cost to borrow surges 234% — signaling acute scarcity despite falling short positions.
- Market cap
- $210292
- Next earnings
- 13 Nov 2026
Key data as of 7 Nov 2026
Latest signals on JAGX
- Short Interest
JAGX short interest plummets 25.3% in a week to 2.9% of float, lowest level in months, as cost to borrow surges 234% — signaling acute scarcity despite falling short positions.
- Utilization
JAGX SI utilization hits 90.68%, approaching 52-week high of 100% as short interest surges 18% in one day to 4.12% of float.
- Cost to Borrow
JAGX cost to borrow surges 178% in one week to 52.0%, highest level in recent history. Utilization stands at 91%, signaling extreme scarcity of shares to borrow amid short squeeze dynamics.
- Options
JAGX put/call ratio plunges to 0.0186, down from the 20-day average of 0.0281 — a Z-score of -4.18 signals extreme call-side skew.
JAGX news and analysis
RSSNo long-form analysis yet for JAGX. Pulse alerts and the live data picture are available on ORTEX.
Open JAGX on ORTEX →Want the live picture for JAGX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JAGX — free to start on ORTEX.
Sign up for free →Open JAGX on ORTEX